Amneal Pharmaceuticals Cleared by FDA to Sell Generic Versio

Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise

-- Amneal Pharmaceuticals rallied Wednesday after the US Food and Drug Administration approved its generic version of the nasal spray used to treat opioid overdose.
Amneal's Naloxone HCI nasal spray...

Related Keywords

United States , , Company Specialty , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals , Markets ,

© 2025 Vimarsana